Mutant myocilin is degraded6,21–24 when cellular levels of Grp94 are reduced using siRNA, as well as when Grp94 is inhibited pharmacologically in cells and in the myocilin-glaucoma mouse model18. This evidence concerns the gene MYOC and glaucoma.